Kenneth R. Heilbrunn
Keine laufenden Positionen mehr
Profil
Kenneth R.
Heilbrunn is Vice President of Clinical Development for La Jolla Pharmaceutical Co. Dr. Heilbrunn is Chief Medical Officer of Cadence Pharmaceuticals, Inc. He received a BA degree from Brown University and a PhD from New York Medical College.
Ehemalige bekannte Positionen von Kenneth R. Heilbrunn
| Unternehmen | Position | Ende |
|---|---|---|
| CADENCE PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.09.2006 |
| LA JOLLA PHARMACEUTICAL COMPANY | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Kenneth R. Heilbrunn
| New York Medical College | Doctorate Degree |
| Brown University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Mallinckrodt Hospital Products, Inc. operates as a biopharmaceutical company, which develops and commercializes proprietary product candidates used in the hospital setting. The firm offers OFIRMEV (acetaminophen injection), a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The company was founded by Theodore R. Schroeder, David A. Socks, and Cam L. Garner on May 26, 2004 and is headquartered in Hazelwood, MO. | Health Technology |
